Cargando…

Validation of the Dutch Version of the Brief Negative Symptom Scale

PURPOSE: The Brief Negative Symptom Scale (BNSS) was developed to measure negative symptoms of schizophrenia. However, the Dutch translation of this instrument, called the “Korte Schaal voor Negatieve Symptomen” (KSNS), has not yet been validated. This study investigates the validity and reliability...

Descripción completa

Detalles Bibliográficos
Autores principales: Seelen-de Lang, Birgit L, Boumans, Christien E, Nijman, Henk L I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605941/
https://www.ncbi.nlm.nih.gov/pubmed/33154643
http://dx.doi.org/10.2147/NDT.S269037
_version_ 1783604408762761216
author Seelen-de Lang, Birgit L
Boumans, Christien E
Nijman, Henk L I
author_facet Seelen-de Lang, Birgit L
Boumans, Christien E
Nijman, Henk L I
author_sort Seelen-de Lang, Birgit L
collection PubMed
description PURPOSE: The Brief Negative Symptom Scale (BNSS) was developed to measure negative symptoms of schizophrenia. However, the Dutch translation of this instrument, called the “Korte Schaal voor Negatieve Symptomen” (KSNS), has not yet been validated. This study investigates the validity and reliability of this Dutch version of the instrument. PATIENTS AND METHODS: The Psychotic Symptom Rating Scale (PSYRATS), Calgary Depression Scale for Schizophrenia (CDSS), the Health of the Nation Scale (HoNOS) and the KSNS were used for routine outcome monitoring to measure symptoms in 28 patients with a psychotic disorder who were being treated on a long-stay ward. RESULTS: The internal consistency of the KSNS is fair to good. The inter-rater reliability is excellent. The concurrent validity is moderate but acceptable. The correlations between the KSNS and scales for depression and positive symptoms were not significant, which indicate good divergent validity. CONCLUSION: Despite the small sample size of the current study, we conclude that the BNSS, called the KSNS in Dutch, appears to be a reliable and valid tool for investigating negative symptoms in detail in patients with psychotic disorders.
format Online
Article
Text
id pubmed-7605941
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-76059412020-11-04 Validation of the Dutch Version of the Brief Negative Symptom Scale Seelen-de Lang, Birgit L Boumans, Christien E Nijman, Henk L I Neuropsychiatr Dis Treat Original Research PURPOSE: The Brief Negative Symptom Scale (BNSS) was developed to measure negative symptoms of schizophrenia. However, the Dutch translation of this instrument, called the “Korte Schaal voor Negatieve Symptomen” (KSNS), has not yet been validated. This study investigates the validity and reliability of this Dutch version of the instrument. PATIENTS AND METHODS: The Psychotic Symptom Rating Scale (PSYRATS), Calgary Depression Scale for Schizophrenia (CDSS), the Health of the Nation Scale (HoNOS) and the KSNS were used for routine outcome monitoring to measure symptoms in 28 patients with a psychotic disorder who were being treated on a long-stay ward. RESULTS: The internal consistency of the KSNS is fair to good. The inter-rater reliability is excellent. The concurrent validity is moderate but acceptable. The correlations between the KSNS and scales for depression and positive symptoms were not significant, which indicate good divergent validity. CONCLUSION: Despite the small sample size of the current study, we conclude that the BNSS, called the KSNS in Dutch, appears to be a reliable and valid tool for investigating negative symptoms in detail in patients with psychotic disorders. Dove 2020-10-29 /pmc/articles/PMC7605941/ /pubmed/33154643 http://dx.doi.org/10.2147/NDT.S269037 Text en © 2020 Seelen-de Lang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Seelen-de Lang, Birgit L
Boumans, Christien E
Nijman, Henk L I
Validation of the Dutch Version of the Brief Negative Symptom Scale
title Validation of the Dutch Version of the Brief Negative Symptom Scale
title_full Validation of the Dutch Version of the Brief Negative Symptom Scale
title_fullStr Validation of the Dutch Version of the Brief Negative Symptom Scale
title_full_unstemmed Validation of the Dutch Version of the Brief Negative Symptom Scale
title_short Validation of the Dutch Version of the Brief Negative Symptom Scale
title_sort validation of the dutch version of the brief negative symptom scale
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605941/
https://www.ncbi.nlm.nih.gov/pubmed/33154643
http://dx.doi.org/10.2147/NDT.S269037
work_keys_str_mv AT seelendelangbirgitl validationofthedutchversionofthebriefnegativesymptomscale
AT boumanschristiene validationofthedutchversionofthebriefnegativesymptomscale
AT nijmanhenkli validationofthedutchversionofthebriefnegativesymptomscale